Latest news with #EdelsonLechtzin
Associated Press
10 hours ago
- Business
- Associated Press
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Aflac Incorporated Customers Whose Data May Have Been Compromised
NEWTOWN, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Aflac Incorporated ('Aflac'). Aflac learned of suspicious activity on its network or about June 12, 2025. About Aflac Incorporated Aflac, a Fortune 500 company, is known for its specialized insurance products that help cover expenses that health insurance may not. Originally established as the American Family Life Assurance Company of Columbus, it officially shortened its name to Aflac in 1989. What happened? On or around June 12, 2025, Aflac discovered suspicious activity on its network. They immediately launched an investigation and have since determined that this breach was caused by a group of cybercriminals, who potentially gained access to personal information. What type of information was stolen? The personal information in the compromised files may have included: How can I protect my personal data? If you receive a data breach notification concerning Aflac, you must guard against identity theft and fraud by regularly reviewing your account statements and monitoring your credit reports for suspicious or unauthorized activity. Edelson Lechtzin LLP is investigating a class action lawsuit to seek legal remedies for individuals whose sensitive personal data may have been compromised by the Aflac data breach. For more information, please contact: Marc H. Edelson, Esq. EDELSON LECHTZIN LLP 411 S. State Street, Suite N-300 Newtown, PA 18940 Phone: 844-696-7492 ext. 2 Email: [email protected] About Edelson Lechtzin LLP Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and catastrophic injuries. This press release may be considered Attorney Advertising in some jurisdictions.
Yahoo
07-06-2025
- Business
- Yahoo
Cable One, Inc. (CABO) Faces Legal Scrutiny from Edelson Lechtzin LLP
Citing possible breaches of federal securities regulations, Edelson Lechtzin LLP has launched an investigation into Cable One, Inc. (NYSE:CABO). The inquiry follows serious concerns regarding potential misrepresentation of the company's operational outlook ahead of its first-quarter earnings announcement, which sharply missed analyst expectations and resulted in a market backlash. A customer in their home enjoying premium channels, high-definition set-top boxes, and whole-home DVRs. On May 1, 2025, Cable One, Inc. (NYSE:CABO) disclosed disappointing Q1 figures and said it would suspend its previously anticipated dividend. These results and announcements, deviating from the earlier guidance, prompted skepticism from analysts at KeyBanc and Raymond James, who criticized the company's previous forecasts on subscriber and broadband revenue growth. The stock quickly plummeted by 41.79%, reaching $152.51 per share on May 2. Having launched an inquiry on Cable One, Inc. (NYSE:CABO), Edelson Lechtzin LLP calls for those with non-public information related to the company to come forward and assist in the investigation. The probe has been initiated amid CEO Julia M. Laulis's retirement. Laulis has held on to the role for more than two decades at Cable One, Inc. (NYSE:CABO) and has over 40 years of expertise in the cable sector. Founded in Arizona, Cable One, Inc. (NYSE:CABO) delivers broadband internet, voice, and video services across underserved regions in the U.S. The company's core operations are centered around subscriber growth and infrastructure upgrades, areas that are now under investor scrutiny. While we acknowledge the potential of CABO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
07-06-2025
- Business
- Yahoo
Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP
On June 4, 2025, Edelson Lechtzin LLP announced that it has initiated an inquiry into whether the healthcare technology company, Semler Scientific, Inc. (NASDAQ:SMLR), misled investors about its business operations regarding claims tied to its QuantaFlo diagnostic device. A doctor in focus surrounded by colleagues in a hospital setting. In an annual report filed by Semler Scientific, Inc. (NASDAQ:SMLR) on February 28, 2025, the company disclosed that the U.S. Department of Justice (DOJ) was evaluating a potential False Claims Act case. The report triggered immediate market reaction, with the company's shares plummeting by 9.4% to close at $38.89 on March 3. Initiating the inquiry, Edelson Lechtzin LLP has asked for the public and stakeholders' help. Edelson urges those with non-public information regarding Semler Scientific, Inc. (NASDAQ:SMLR) to come forward and assist them in the investigation. It also encourages the company's investors who have suffered losses to follow the inquiry to learn more. The investor confidence has been significantly fluctuating since the disclosure. The stock's performance, which gained 6.49% last month, declined by 13.46% last week. The California-based company, Semler Scientific, Inc. (NASDAQ:SMLR), is known for developing non-invasive medical tools, with QuantaFlo being its most prominent product. Focusing on early disease detection and chronic condition management, the company has positioned itself between healthcare and technology. While we acknowledge the potential of SMLR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Sign in to access your portfolio
